Balixafortide (a CXCR4 antagonist) plus eribulin in HER2 negative metastatic breast cancer: Dose-response analysis of efficacy from phase I single-arm trial. R-DOTAP (Versamune): A novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results